Chloroquine-resistant Plasmodium falciparum infections among UK travellers returning with malaria after chloroquine prophylaxis

Journal of Antimicrobial Chemotherapy

Volumn 59, Issue 6, 2007, Pages 1197-1199

  Sutherland, Colin J ^a,b   Haustein, Thomas ^a   Gadalla, Nahla ^b   Armstrong, Margaret ^a   Doherty, Justin F ^a,b   Chiodini, Peter L ^a,b  

^a HOSPITAL FOR TROPICAL DISEASES   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Compliance; Pfcrt; Real time PCR

Indexed keywords

ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE PLUS PROGUANIL; DOXYCYCLINE; MEFLOQUINE; PROGUANIL; PYRIMETHAMINE;

ALLELE; ARTICLE; CHEMOPROPHYLAXIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALARIA CONTROL; MALARIA FALCIPARUM; NONHUMAN; PARASITE IDENTIFICATION; PATIENT COMPLIANCE; PLASMODIUM FALCIPARUM; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; TRAVEL; UNITED KINGDOM; WILD TYPE;

ALLELES; ANIMALS; CHLOROGUANIDE; CHLOROQUINE; DRUG RESISTANCE; GENOTYPE; GREAT BRITAIN; HUMANS; MALARIA, FALCIPARUM; MEMBRANE TRANSPORT PROTEINS; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 34447570726     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm104     Document Type: Article

References (10)

1. Health Protection Agency. http://www.hpa.org.uk/infections/topics_az/ malaria/pdf/Malaria2003.pdf (27 February 2007, date last accessed).
2. World Health Organization. Susceptibility of Plasmodium falciparum to Antimalarial Drugs. Report on Global Monitoring 1996-2004. Geneva, Switzerland: WHO. 2005; 35-9.
3. Djimde A, Doumbo OK, Steketee RW et al. Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria. Lancet 2001; 358: 890-1.
4. Berry A, Vessiere, A, Fabre R et al. Pfcrt K76T mutation and its associations in imported Plasmodium falciparum malaria cases. Infect Genet Evol 2004; 4: 361-4.
5. Jennings RM, De Souza JB, Todd JE et al. Imported Plasmodium falciparum malaria: Are patients originating from endemic areas less likely to develop severe disease? A prospective, observational study. Am J Trop Med Hyg 2006; 75: 1195-9.
6. Padley D, Moody AH, Chiodini PL et al. Use of a rapid, single-round, multiplex PCR to detect malarial parasites and identify the species present. Ann Trop Med Parasitol 2003; 97: 131-7.
7. Wilson PE, Kazadi W, Kamwendo DD et al. Prevalence of pfcrt mutations in Congolese and Malawian Plasmodium falciparum isolates as determined by a new Taqman assay. Acta Trop 2005; 93: 97-106.
8. Shulman CE, Dorman EK, Cutts F et al. Intermittent sulfadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: A randomised placebo-controlled trial. Lancet 1999; 353: 632-6.
9. Schellenberg D, Menedez C, Aponte JA et al. Intermittent preventive antimalarial treatment for Tanzanian infants: Follow-up to age 2 years of a randomised, placebo-controlled trial. Lancet 2005; 365: 1481-3.
10. Sutherland CJ, Drakeley CJ, Obisike U et al. The addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children delays, but does not prevent, treatment failure. Am J Trop Med Hyg 2003; 69: 19-25.